Cargo Therapeutics

Public

San Carlos, CaliforniaBiotechwww.cargo-tx.com

Cargo Therapeutics is now publicly traded

The data on this page reflects Cargo Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Nov 9, 2023

Last Round

M&A

Aug 19, 2025

Est. Valuation at Exit

$211.8M

Total Funding Raised

$846.05M

Company Overview

Cargo Therapeutics is a biotechnology company focused on developing next-generation, potentially curative cell therapies for cancer patients, utilizing innovative programs and manufacturing strategies to overcome the limitations of existing treatments.

Sector

Biotech

AI Layer

Non-AI

Keywords

autologous CD22 CAR T-cell therapychimeric antigen receptor (CAR) T-cell therapycell therapy for large B-cell lymphoma (LBCL)therapy for CD19 CAR-T treatment failureCD22-targeted cancer immunotherapycell therapy for hematologic malignanciestri-specific CAR T-cell therapyallogeneic CAR T-cell platformcell therapy for pediatric B-cell Acute Lymphoblastic Leukemiaclinical-stage cancer immunotherapy development

Cargo Therapeutics Comparables

Compare Cargo Therapeutics with similar companies based on industry and business-model similarity.

Cargo Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Cargo Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Aug 19, 2025
Private Placement	May 28, 2024
IPO	Nov 9, 2023
Series A	Mar 1, 2023
Convertible Debt	Jan 1, 2023
Seed	Jan 1, 2022

View all Funding Rounds

Cargo Therapeutics Investors

Notable investors and investment history

Cargo Therapeutics investors
Investor	Rounds
EcoR1 Capital	Private Placement
Jefferies	IPO
Janus Henderson Group	Series A
Perceptive Advisors	Private Placement, Series A
Ally Bridge Group	Series A, Private Placement
Heartland Healthcare Capital	Series A
Xontogeny	Series A

View all Investors

Cargo Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cargo Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSan Carlos, California

Employee Range43

Year Founded2021

Last FundingAug 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.